From: Systems and precision medicine approaches to diabetes heterogeneity: a Big Data perspective
1. Can diabetes trajectories be considered as multidimensional objects such that associated risks and comorbidities can be more accurately accounted for? |
2. Are electronic health records (EHR) innovative or even disruptive when inducing re-phenotyping and new patient stratifications? |
3. Can we build effectively actionable clinical decision support systems (CDSS) from predictive modelling and patient-driven analytics? |